Research Topics
Species | O H KlungelSummaryAffiliation: Utrecht University Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Excess stroke among hypertensive men and women attributable to undertreatment of hypertensionO H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Pharmacy, University of Utrecht, The Netherlands
Stroke 30:1312-8. 1999..The aim of our study was to investigate the consequences of undertreatment of hypertension for women and men in terms of stroke occurrence...
Perceived diabetes status is independently associated with glucose monitoring behaviour among type 2 diabetes mellitus patientsOlaf H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, P O BOX 80082, 3508 TB Utrecht, The Netherlands
Prim Care Diabetes 2:25-30. 2008..To investigate if patients' perceptions of their diabetes status is related to blood glucose self-monitoring (SMBG) behaviour, independent of self-reported disease severity...
Methods to assess intended effects of drug treatment in observational studies are reviewedOlaf H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences UIPS, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands
J Clin Epidemiol 57:1223-31. 2004..To review methods that seek to adjust for confounding in observational studies when assessing intended drug effects...
Lipid-lowering drug use and cardiovascular events after myocardial infarctionOlaf H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands
Ann Pharmacother 36:751-7. 2002....
Antihypertensive drug therapies and the risk of ischemic strokeO H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Sorbonnelann 16, 3584 CA Utrecht, The Netherlands
Arch Intern Med 161:37-43. 2001..The relative effectiveness of various antihypertensive drugs with regard to the reduction of stroke incidence remains uncertain...
Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressureO H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands
J Clin Epidemiol 53:1158-63. 2000..1-8.4% overestimation). When repeated measurements of blood pressure are not available in a population study for a sample of that same study, it is advisable to use data from another study to correct for WPV...
Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patientsO H Klungel
Department of Epidemiology, Medicine, Cardiovascular Health Research Unit, University of Washington, Seattle, USA
Stroke 31:420-4. 2000..We estimated the proportion of strokes occurring among treated hypertensive patients that may be attributable to uncontrolled blood pressure...
Sex differences in the medication choice for hypertension in general practice. A study with written case simulationsO H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Pharmacy, Universiteit Utrecht, The Netherlands
Pharm World Sci 22:140-6. 2000..These considerations may also play a role in the sex difference in the choice of calcium antagonists and angiotensin converting enzyme inhibitors and require further investigation...
The association between antihypertensive drug therapies and plasma lipid levels in the general populationA H Maitland-van der Zee
Utrecht Institute for Pharmaceutical Sciences (UIPS, Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht University, Utrecht, The Netherlands
J Hum Hypertens 15:701-5. 2001..The combination of a diuretic and a beta-blocker was associated with a worse lipid profile...
Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensivesO Bozkurt
Faculty of Science, Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
J Hum Hypertens 22:774-80. 2008....
Is drug treatment of hypertension in clinical practice as effective as in randomized controlled trials with regard to the reduction of the incidence of stroke?O H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, P O BOX 80082, 3508 TB Utrecht, The Netherlands
Epidemiology 12:339-44. 2001..The relative risk reduction that we found was similar to those found in randomized controlled trials...
Cardiovascular drug use and hospitalizations attributable to type 2 diabetesJ A Erkens
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht University, Utrecht, The Netherlands
Diabetes Care 24:1428-32. 2001..To investigate cardiovascular drug use and hospitalizations attributable to type 2 diabetes from 1 year before until 6 years after the start of oral antidiabetic therapy...
Influence of correction for within-person variability in blood pressure on the prevalence, awareness, treatment, and control of hypertensionO H Klungel
Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Pharmacy, Utrecht University, The Netherlands
Am J Hypertens 13:88-91. 2000..It may be advisable to perform a correction for within-person variability to obtain valid prevalence estimates in surveys that only take one or two measurements of blood pressure...
Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosisH Schelleman
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Br J Clin Pharmacol 64:57-66. 2007....
Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levelsA K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, The Netherlands
Drug Saf 24:443-56. 2001..In cases of extreme hyperlipidaemia, medication use should be reassessed...
Comparison of various measures for assessing medication refill adherence using prescription dataN M Vink
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Pharmacoepidemiol Drug Saf 18:159-65. 2009..Few studies have made direct comparisons, and little is known about the accuracy of these measures in patients on a multiple-drug regimen...
Determinants of DNA yield and purity collected with buccal cell samplesD B M A van Wieren-de Wijer
Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
Eur J Epidemiol 24:677-82. 2009..95). One technician obtained significantly lower DNA yields. Older age was associated with lower DNA purity. In conclusion, DNA yield from buccal swabs was higher in men and DNA purity was associated with age and the use of diuretics...
Undertreatment of hypercholesterolaemia: a population-based studyA K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, PO Box 80082, 3508 TB Utrecht, The Netherlands
Br J Clin Pharmacol 55:389-97. 2003....
Comparison of different methods to estimate prevalence of drug use by using pharmacy recordsA K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
J Clin Epidemiol 54:1181-6. 2001..However, defined daily doses should not be used to estimate (point) prevalences of drug use because this measure is significantly influenced by prescribed dosage regimens...
Prevalence and determinants of undertreatment of hypertension in the NetherlandsH Schelleman
Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands
J Hum Hypertens 18:317-24. 2004..Therefore, the detection and control of hypertension in the Netherlands needs to improve. Several groups of hypertensives were identified that need additional care and attention...
Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patientsJ A Erkens
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands
Eur Heart J 23:1575-9. 2002..CONCLUSION: Our results suggest that treatment with fluorquinolones in doses commonly prescribed in routine clinical practice is associated with a reduction in the risk of coronary heart diseases among diabetes mellitus type 2 patients...
Interpretation and inference in noninferiority randomized controlled trials in drug researchG Wangge
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands
Clin Pharmacol Ther 88:420-3. 2010..On the basis of our review of 232 trials, we conclude that the interpretation and inference of NI trials are complicated, partly because of the incompleteness of the information...
Costs and effects of combining stenting and abciximab (ReoPro) in daily practiceJ E Zwart-van Rijkom
Utrecht University, Department of Pharmaco epidemiology and Pharmacotherapy, Utrecht, The Netherlands
Int J Cardiol 77:299-303. 2001..We conducted a study in daily clinical practice comparing stented and non-stented patients undergoing coronary angioplasty with abciximab administration. Furthermore, we compare our results with the findings of the EPISTENT trial...
Use of statins is associated with an increased risk of rheumatoid arthritisH J I de Jong
Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
Ann Rheum Dis 71:648-54. 2012..The authors studied whether statin use was associated with an increased risk of developing RA by conducting a case-control study using the Netherlands Information Network of General Practice database...
The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillationH A VAN DEN Ham
Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK
J Thromb Haemost 11:107-15. 2013..Conclusion: Cluster analysis of INR patterns improved the prediction of clinical outcomes over TTR and may help to identify warfarin users who need additional anticoagulation monitoring...
Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United StatesT P Khong
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Universiteitsweg 99, Utrecht, The Netherlands
Calcif Tissue Int 91:24-31. 2012..8 % and 8.2 %. During the next phase of the IMI-PROTECT study, a comparison with individual patient data will show whether this approach is valid...
An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in The NetherlandsR M Herings
PHARMO Institute, Utrecht, The Netherlands
Pharmacoeconomics 19:655-65. 2001..To use the population attributable risk (PAR) to estimate the treatment costs resulting from nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal (GI) morbidity...
Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockersHedi Schelleman
Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands
Eur J Hum Genet 15:478-84. 2007..ACE-inhibitor users with at least one copy of the 235T-allele of the AGT gene might have an increased risk of MI and stroke...
Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levelsAaron Isaacs
Genetic Epidemiology Unit, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
J Clin Endocrinol Metab 92:2680-7. 2007..The objectives of the current study were to characterize the effect of the hepatic lipase variant, and its interaction with the CETP variant, in terms of cholesterol levels, atherosclerosis, and risk of myocardial infarction (MI)...
Effects of the renin-angiotensin system genes and salt sensitivity genes on blood pressure and atherosclerosis in the total population and patients with type 2 diabetesMojgan Yazdanpanah
Genetic Epidemiology Unit, Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
Diabetes 56:1905-12. 2007..04 mm, P = 0.02). We found that among type 2 diabetic patients, mean systolic blood pressure, pulse pressure, and risk of hypertension increased with the number of risk genotypes for the RAS genes and the salt sensitivity genes...
Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based studyBoris L G Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
J Hypertens 25:689-97. 2007..To assess patterns of restarting antihypertensive drugs after a prolonged period of discontinuation...
Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) studyAnke Hilse Maitland-van der Zee
School of Public Health, University of Texas Health Science Center at Houston, 1200 Hermann Pressler, Houston TX, USA
Am Heart J 153:54-8. 2007....
Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort studyFernie J A Penning-van Beest
PHARMO Institute, PO Box 85222, 3508 AE Utrecht, The Netherlands
Eur Heart J 28:154-9. 2007..To investigate the 'real world' effectiveness of robust statin therapy, focusing on the effect of dose and early treatment discontinuation on the risk of hospitalization for acute myocardial infarction (AMI)...
Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam studyPearl D Gumbs
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceuticals Sciences (UIPS, Utrecht University, Utrecht, The Netherlands
Drugs Aging 23:733-41. 2006..CONCLUSION: Reallocation of resources used for statin therapy from those receiving non-guidelines-indicated treatment to those being undertreated could lead to a more efficient use of resources...
A comparison of two multiple-characteristic decision-making models for the comparison of antihypertensive drug classes: Simple Additive Weighting (SAW) and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS)Boris L G Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands
Am J Cardiovasc Drugs 6:251-8. 2006..Both methods are valuable tools in the development of evidence-based pharmacotherapy...
CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?Tom Schalekamp
Department of Pharmacoepidemiology and Pharmacotherapy, University Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Clin Pharmacol Ther 79:511-20. 2006
The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressureHedi Schelleman
Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands
Eur J Hum Genet 14:860-6. 2006..33 mmHg (95% CI:-9.66 to 5.01). The G460W polymorphism and the M235T polymorphism did not modify the difference in blood pressure levels among subjects who used diuretics, beta-blockers, calcium antagonists, or ACE inhibitors...
Regional influences on the dispensing of glucose test strips in Dutch community pharmaciesMichiel J Storimans
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands
Pharm World Sci 28:26-32. 2006..This suggests that implementing practice guidelines for diabetes care in community pharmacy requires different approaches in different regions...
Differences in the association between structural factors and diabetes self-monitoring supportMichiel J Storimans
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 26, Utrecht, The Netherlands
Pharm World Sci 29:676-82. 2007..To determine if the association between the level of community pharmacy diabetes services and six of its reported determinants is influenced by the definition of these services...
Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variantBas J M Peters
Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht University, Utrecht, The Netherlands
Pharmacogenet Genomics 18:631-6. 2008..Therefore, we assessed whether the effectiveness of statins in reducing the risk of MI was modified by the GNB3 C825T polymorphism...
Systematic differences in treatment effect estimates between propensity score methods and logistic regressionEdwin P Martens
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences UIPS, Utrecht University, Utrecht, The Netherlands
Int J Epidemiol 37:1142-7. 2008..From literature reviews it has been concluded that treatment effect estimates from both methods are quite similar. With this study we will show that there are systematic differences which can be substantial...
Effect of persistent use of antihypertensives on blood pressure goal attainmentNancy S Breekveldt-Postma
PHARMO Institute, Utrecht, The Netherlands
Curr Med Res Opin 24:1025-31. 2008..The present study investigates the relationship between persistence with antihypertensive drugs (AHT) and blood pressure (BP) goal attainment in daily clinical practice...
The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control studyHieronymus J Derijks
Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Faculty of Science, Utrecht University, Utrecht, The Netherlands
Pharmacoepidemiol Drug Saf 17:336-44. 2008..We have carried out a nested case-control study among diabetic patients to assess the risk of hypoglycaemia requiring hospitalisation associated with the use of antidepressants...
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarinsTom Schalekamp
Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
Arch Intern Med 168:180-5. 2008....
A cross-national study of the persistence of antihypertensive medication use in the elderlyBoris L G Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands b l g
J Hypertens 26:145-53. 2008..The aim of this study was to describe and compare patterns of use of antihypertensive drugs in a population of elderly patients in the United States (Pennsylvania), Canada (British Columbia) and the Netherlands...
The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and strokeNancy S Breekveldt-Postma
PHARMO Institute, Utrecht, The Netherlands
Curr Med Res Opin 24:121-7. 2008..The present study investigates the effect of early treatment discontinuation with antihypertensive drugs on the risk of acute myocardial infarction (AMI) or stroke in daily clinical practice...
Pharmacogenetics of glucose-lowering drug treatment: a systematic reviewOzlem Bozkurt
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Mol Diagn Ther 11:291-302. 2007..Future studies with adequate sample sizes in which several SNPs in multiple candidate genes are genotyped in patients with diabetes should provide reliable information on genetic variants and response to glucose-lowering drugs...
Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methodsEdwin P Martens
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Pharmacoepidemiol Drug Saf 17:1-8. 2008..To compare adjusted effects of drug treatment for hypertension on the risk of stroke from propensity score (PS) methods with a multivariable Cox proportional hazards (Cox PH) regression in an observational study with censored data...
Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitutionPearl D Gumbs
Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Utrecht, The Netherlands
Br J Clin Pharmacol 64:680-5. 2007..To assess the potential annual savings due to generic and therapeutic substitution of statin therapy for the general Dutch population, taking the patients medical history into account...
The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam StudyAaron Isaacs
Genetic Epidemiology Unit, Erasmus Medical Center, Rotterdam, The Netherlands
Eur J Cardiovasc Prev Rehabil 14:419-21. 2007..The effect of the cholesteryl ester transfer protein (CETP) I405V polymorphism on lipid levels, atherosclerosis and myocardial infarction (MI) was examined in 6421 participants from the Rotterdam Study...
Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetesMirjam J Knol
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands
Psychosom Med 69:300-5. 2007..To investigate if disturbed glucose homeostasis or known diagnosis of diabetes was associated with depressive symptoms. The reason for the increased prevalence of depression in patients with Type 2 diabetes mellitus (DM2) is unknown...
Prescribing behaviour according to Dutch and European guidelines on the management of hypercholesterolaemia (1992-1999)Aukje K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS, Utrecht University, Utrecht, The Netherlands
Br J Clin Pharmacol 61:592-600. 2006..As long as existing guidelines are as discrepant as they are now, variation in agreement between physicians' prescribing and guideline recommendations is unavoidable...
Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?Aukje K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Br J Clin Pharmacol 53:379-85. 2002..To assess time trends in lipid lowering drug use in The Netherlands...
The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimenBoris L G Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands
J Hypertens 22:1831-7. 2004..Pharmacists and physicians can use pharmacy data, although data tend to overestimate actual compliance, to assess and improve compliance with antihypertensive drugs, before modifying treatment regimens...
Drug-gene interactions between genetic polymorphisms and antihypertensive therapyHedi Schelleman
Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands
Drugs 64:1801-16. 2004..Unfortunately, the quality of these studies is quite variable. Given the methodological problems, the results from the candidate gene studies are still inconclusive and further research is necessary...
Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO studyWim G Goettsch
PHARMO Institute, Utrecht, The Netherlands
Curr Med Res Opin 20:1025-33. 2004..To study the use and effectiveness of lipid-lowering drugs with respect to lowering of cholesterol levels in routine daily practice...
Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphismAnke-Hilse Maitland-van der Zee
Atherosclerosis 175:377-9. 2004
Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in menAnke Hilse Maitland-van der Zee
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University Utrecht, The Netherlands
Pharmacogenetics 14:53-60. 2004..If other studies confirm that men with the DD genotype do not benefit from treatment with statins, screening for ACE genotype in men most likely will be a cost-effective strategy before initiating statin therapy...
Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patientsJoelle A Erkens
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands
Pharmacoepidemiol Drug Saf 13:139-46. 2004..The objective of this study was to determine the association between different antihypertensive drug therapies and lower extremity amputations (LEAs) in type 2 diabetes patients...
Comparison of two methodologies to analyze exposure to statins in an observational study on effectivenessAnke Hilse Maitland-van der Zee
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS, Utrecht University, Sorbonnelaan 16, P.O. Box 80082, 3508 TB, The Netherlands
J Clin Epidemiol 57:237-42. 2004..59-1.39). CONCLUSION: Our results suggest that use of a time-dependent exposure definition is more accurate because estimates of effectiveness were more in agreement with results from randomized controlled trials of statin treatment...
Dispensing glucose test materials in Dutch community pharmaciesMichiel J Storimans
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands
Pharm World Sci 26:52-5. 2004..To assess the proportion of diabetic patients who collect self-monitoring equipment for glucose testing in Dutch community pharmacies...
Failure to continue lipid-lowering drug use following the withdrawal of cerivastatinAukje K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Drug Saf 27:63-70. 2004..Persistence with lipid-lowering drug use is important in order for patients to gain full treatment benefit. The withdrawal of cerivastatin from the market may have affected persistence due to the fear of serious adverse effects...
Adherence to and dosing of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypesAnke Hilse Maitland-van der Zee
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Utrecht, The Netherlands
Pharmacogenetics 13:219-23. 2003..18 (CI 1.01-10.03) in men. The apoE genotype is associated with discontinuation of statins. This suggests that subjects who are genetically prone to develop hypercholesterolemia show the highest risk of discontinuation of treatment...
Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?José A Spoelstra
Julius Center for General Practice and Patient Oriented Research, University Medical Center Utrecht, HP D01 335, PO Box 85500, 3508 GA Utrecht, Netherlands
Pharmacoepidemiol Drug Saf 12:121-7. 2003..To assess whether switching to insulin therapy in patients with type 2 diabetes mellitus is associated with medication refill compliance of oral hypoglycemic agents...
Myopathy due to statin/fibrate use in the NetherlandsAukje K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
Ann Pharmacother 36:1957-60. 2002..To estimate the number of expected cases of myopathy based on the prevalence of lipid-lowering drug use, and to compare this number with the observed number of cases of myopathy due to lipid-lowering drug use in the Netherlands...
The effectiveness of hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) in the elderly is not influenced by apolipoprotein E genotypeAnke Hilse Maitland-van der Zee
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences UIPS, Utrecht University, Utrecht, The Netherlands
Pharmacogenetics 12:647-53. 2002..The protective effect of statins on total mortality was not statistically significant, but did not seem to differ between subjects with different apoE genotypes...
Quality of hypertension treatment and risk of stroke in the general populationOlaf H Klungel
J Hypertens 20:1949-50. 2002
Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitorsAnke Hilse Maitland-van der Zee
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences UIPS, Utrecht University, Sorbonnelaan 16, P O BOX 80082, The Netherlands
Atherosclerosis 163:213-22. 2002..Determining the genotype will not deny therapy to a subject, but will help in deciding the therapy that will suit the patient best...
Recent trends in (under)treatment of hypercholesterolaemia in the NetherlandsAukje K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Utrecht, The Netherlands
Br J Clin Pharmacol 58:310-6. 2004..To assess recent trends in undertreatment of hypercholesterolaemia (1998-2002)...
Geographic region influences pharmacy's dispensing of blood glucose test stripsMichiel J Storimans
Ann Pharmacother 38:1751-2. 2004
Should rosuvastatin be withdrawn from the market?Stefan R Florentinus
Lancet 364:1577; author reply 1578-9. 2004
Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapyBoris L G Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands
Pharmacoepidemiol Drug Saf 15:587-93. 2006..The pharmacy medication history is a valuable tool for physicians to identify patients who have a high risk on discontinuation with antihypertensive treatment...
Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapyHedi Schelleman
Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, Netherlands
Ann Pharmacother 40:212-8. 2006..There are some indications that the angiotensin-converting enzyme (ACE) gene modifies the response to antihypertensive drugs, but the results have been inconclusive...
Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculationBoris L G Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands
J Clin Epidemiol 59:11-7. 2006..Results of persistence studies are highly influenced by the researchers' method of the maximum allowed treatment gap...
Generic substitution of antihypertensive drugs: does it affect adherence?Boris L G Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Ann Pharmacother 40:15-20. 2006..However, pharmacists and physicians often find that patients and brand-name manufacturers have doubt about the equivalence of the substituted drug. This may be reflected by decreased adherence to therapy...
Rate and determinants of 10-year persistence with antihypertensive drugsBoris Lg Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, The Netherlands
J Hypertens 23:2101-7. 2005..CONCLUSION: Long-term persistence in daily practice is low compared with persistence observed in randomized clinical trials and should be considered in the choice of a first-line antihypertensive agent...
Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO studyJoelle A Erkens
PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
Pharmacoepidemiol Drug Saf 14:795-803. 2005..The objective of the study is to investigate factors related to treatment persistence among users of antihypertensive (AHT) drugs in daily practice...
Collaborative services among community pharmacies for patients with diabetesMichiel J Storimans
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences and Scientific Institute Dutch Pharmacists, Utrecht, Netherlands
Ann Pharmacother 39:1647-53. 2005..CONCLUSIONS: Local collaboration on the division of roles in diabetes care between healthcare professionals is independently associated with the number of pharmacy services provided to patients performing SMBG...
Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjectsAnke Hilse Maitland-van der Zee
Human Genetics Center, University of Texas Health Science Centre, Houston, TX 77030, USA
Am J Hypertens 18:1077-83. 2005..The aim of this study was to characterize interindividual variation in glucose and lipid responses to hydrochlorothiazide and to identify demographic, environmental, and genetic predictors associated with this variation...
Suboptimal choices and dosing of statins at start of therapyAukje K Mantel-Teeuwisse
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Utrecht, The Netherlands
Br J Clin Pharmacol 60:83-9. 2005..To assess dosing and determinants of the choice of statins among starters of statins...
A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazideAnke Hilse Maitland-van der Zee
Human Genetics Center, University of Texas Health Science Center, Houston, TX 77030, USA
Pharmacogenet Genomics 15:287-93. 2005..To assess the influence of variations in multiple candidate genes on inter-individual variation in diastolic blood pressure (DBP) response to hydrochlorothiazide...
Cardiovascular drug use and differences in the incidence of cardiovascular mortality in elderly Serbian menPaul Hommerson
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, P.O. Box 80082, 3508 TB Utrecht, The Netherlands
Pharm World Sci 27:124-8. 2005..40 [95% CI: 1.61-3.60] and 2.55 [95% CI: 1.72-3.78], respectively. CONCLUSION: The variation in cardiovascular medication use could not explain the excess risk of mortality in the rural Serbian cohorts compared to urban Belgrade...
Economic evaluations of cholesterol-lowering drugs: a critical and systematic reviewPearl D Gumbs
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceuticals Sciences UIPS, Utrecht University, Utrecht, The Netherlands
Pharmacoeconomics 25:187-99. 2007..In general, piggy-back evaluations tended to score higher on quality and may therefore be more valuable in decision making...
Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study (p n/a) by Peter C. Austin, Paul Grootendorst, Sharon-Lise T. Normand, Geoffrey M. Anderson, Statistics in Medicine, PublishedEdwin P Martens
Stat Med 26:3208-10; author reply 3210-2. 2007
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic reviewBoris Lg Van Wijk
Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Utrecht, Netherlands
Ann Pharmacother 39:319-28. 2005..More well-designed and well-conducted studies on the effectiveness of interventions by a community pharmacist to improve patient adherence to chronic medication need to be performed...
Pharmacogenetics in health-care practiceder Zee Anke-Hilse Maitland-van
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Pharm World Sci 26:253-5. 2004
Instrumental variables: application and limitationsEdwin P Martens
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS, Utrecht University, Utrecht, The Netherlands
Epidemiology 17:260-7. 2006..We conclude that instrumental variables can be useful in case of moderate confounding but are less useful when strong confounding exists, because strong instruments cannot be found and assumptions will be easily violated...
